APN
COM:ASPENPHARMA
Aspen Pharmacare
- Stock
Last Close
17,025.00
22/11 15:04
Market Cap
1.03B
Beta: -
Volume Today
1.21M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 7.19B - | 10.53B 46.54% | 12.60B 19.58% | 14B 11.15% | 14.05B 0.34% | 14.57B 3.73% | 15.53B 6.58% | 14.91B 3.99% | 14.59B 2.18% | 17.68B 21.24% | |
average payables | 5.53B - | 5.16B 6.74% | 5.86B 13.73% | 6.75B 15.10% | 4.84B 28.24% | 4.21B 13.13% | 3.65B 13.29% | 3.33B 8.65% | 3.47B 4.08% | 3.81B 9.69% | |
average receivables | 15.10M - | 5.87B 38,741.72% | 12.65B 115.68% | 6.80B 46.25% | 7.31B - | 7.31B 0% | |||||
book value per share | 63.30 - | 74.82 18.18% | 93.12 24.46% | 94.43 1.41% | 109.70 16.16% | 118.78 8.28% | 151.62 27.65% | 143.76 5.18% | 156.60 8.93% | 194.13 23.96% | |
capex per share | -4.45 - | -5.30 19.08% | -6.13 15.80% | -5.70 7.14% | -18.03 216.46% | -7.85 56.45% | -5.89 24.94% | -7.52 27.55% | -5.95 20.79% | -7.16 20.28% | |
capex to depreciation | -2.33 - | -2.33 0.32% | -2 14.29% | -6.00 199.85% | -2.81 53.10% | -1.68 40.33% | -2.08 23.69% | -1.57 24.15% | -1.78 13.00% | ||
capex to operating cash flow | -0.53 - | -0.50 5.56% | -0.88 75.14% | -0.40 54.29% | -1.17 193.15% | -0.60 49.09% | -0.33 45.45% | -0.50 54.36% | -0.50 0.17% | -0.58 14.83% | |
capex to revenue | -0.07 - | -0.07 2.68% | -0.08 17.54% | -0.06 19.76% | -0.19 206.09% | -0.09 52.28% | -0.07 24.49% | -0.09 30.52% | -0.07 23.10% | -0.08 11.85% | |
cash per share | 18.03 - | 19.06 5.67% | 23.88 25.32% | 23.44 1.83% | 22.41 4.39% | 19.67 12.25% | 15.54 21.00% | 18.72 20.48% | 13.65 27.09% | 24.56 79.97% | |
days of inventory on hand | 237.47 - | 208.71 12.11% | 296.95 42.28% | 233.05 21.52% | 252.06 8.16% | 278.84 10.62% | 310.18 11.24% | 245.00 21.01% | 283.42 15.68% | 320.89 13.22% | |
days payables outstanding | 159.10 - | 66.32 58.31% | 171.16 158.07% | 89.11 47.94% | 78.02 12.44% | 74.77 4.16% | 63.67 14.85% | 60.24 5.39% | 65.47 8.68% | 64.96 0.77% | |
days sales outstanding | 0.31 - | 119.96 39,214.79% | 120.49 0.44% | 138.18 - | |||||||
debt to assets | 0.46 - | 0.44 4.86% | 0.42 4.53% | 0.41 1.68% | 0.44 6.14% | 0.39 10.12% | 0.32 18.95% | 0.23 28.64% | 0.20 11.92% | 0.22 9.17% | |
debt to equity | 1.32 - | 1.13 13.81% | 1.03 9.54% | 1.11 8.11% | 1.16 4.36% | 0.88 23.56% | 0.61 30.89% | 0.38 38.01% | 0.31 17.26% | 0.34 8.28% | |
dividend yield | 0.01 - | 0.01 0.61% | 0.01 15.83% | 0.01 51.42% | 0.01 21.65% | 0.03 170.05% | 0.02 - | 0.02 6.06% | |||
earnings yield | 0.04 - | 0.03 13.80% | 0.03 17.87% | 0.04 49.66% | 0.05 31.02% | 0.04 18.01% | 0.07 70.27% | 0.06 8.77% | 0.10 58.59% | 0.06 37.78% | |
enterprise value | 166.09B - | 194.32B 16.99% | 198.04B 1.92% | 168.13B 15.10% | 164.63B 2.08% | 86.75B 47.31% | 100.74B 16.13% | 90.32B 10.34% | 79.05B 12.48% | 99.94B 26.42% | |
enterprise value over ebitda | 21.11 - | 20.27 3.94% | 21.30 5.04% | 17.33 18.60% | 13.39 22.74% | 7.89 41.12% | 9.43 19.61% | 9.17 2.78% | 7.38 19.48% | 9.45 28.01% | |
ev to operating cash flow | 43.30 - | 40.16 7.25% | 61.89 54.11% | 25.87 58.20% | 23.46 9.30% | 14.45 38.40% | 12.20 15.61% | 13.23 8.51% | 14.71 11.15% | 18.10 23.08% | |
ev to sales | 5.63 - | 5.38 4.42% | 5.56 3.43% | 4.08 26.64% | 3.86 5.29% | 2.23 42.26% | 2.61 16.81% | 2.39 8.25% | 2.05 14.39% | 2.45 19.89% | |
free cash flow per share | 3.96 - | 5.31 33.95% | 0.88 83.48% | 8.55 875% | -2.65 131.05% | 5.30 299.75% | 12.20 130.21% | 7.43 39.07% | 5.91 20.52% | 5.27 10.90% | |
free cash flow yield | 0.01 - | 0.01 11.21% | 0.00 83.59% | 0.03 1,130.31% | -0.01 134.52% | 0.05 592.88% | 0.09 67.87% | 0.05 46.05% | 0.04 7.34% | 0.03 32.53% | |
graham net net | -88.37 - | -87.97 0.45% | -76.52 13.01% | -99.69 30.28% | -143.00 43.44% | -113.50 20.63% | -106.58 6.10% | -63.10 40.79% | -34.01 46.10% | -61.53 80.91% | |
graham number | 125.05 - | 138.52 10.77% | 140.50 1.43% | 154.09 9.67% | 180.28 17.00% | 108.14 40.02% | 186.69 72.64% | 184.54 1.16% | 224.65 21.74% | 226.73 0.93% | |
income quality | 0.48 - | 0.57 18.09% | 0.36 37.91% | 0.78 120.26% | 0.76 3.00% | 1.19 56.02% | 1.11 6.08% | 1.03 7.64% | 0.62 39.72% | 0.71 13.87% | |
intangibles to total assets | 0.51 - | 0.52 0.43% | 0.53 2.55% | 0.57 7.26% | 0.59 4.01% | 0.58 1.35% | 0.59 1.28% | 0.54 7.87% | 0.53 2.92% | 0.51 2.86% | |
interest coverage | 5.20 - | 4.21 19.06% | 4.50 6.87% | 3.77 16.16% | 4.03 6.82% | 4.17 3.49% | 4.47 7.27% | 5.87 31.18% | 11.33 93.13% | 5.91 47.88% | |
interest debt per share | 86.42 - | 89.24 3.26% | 99.91 11.96% | 109.55 9.65% | 131.99 20.48% | 110.20 16.52% | 96.16 12.73% | 57.13 40.59% | 50.80 11.08% | 68.90 35.63% | |
inventory turnover | 1.54 - | 1.75 13.78% | 1.23 29.71% | 1.57 27.42% | 1.45 7.54% | 1.31 9.60% | 1.18 10.10% | 1.49 26.60% | 1.29 13.56% | 1.14 11.68% | |
invested capital | 1.32 - | 1.13 13.81% | 1.03 9.54% | 1.11 8.11% | 1.16 4.36% | 0.88 23.56% | 0.61 30.89% | 0.38 38.01% | 0.31 17.26% | 0.34 8.28% | |
market cap | 136.33B - | 164.27B 20.49% | 165.34B 0.66% | 131.03B 20.75% | 117.85B 10.06% | 47.76B 59.47% | 65.51B 37.16% | 73.99B 12.95% | 62.99B 14.88% | 81.57B 29.50% | |
net current asset value | -22.46B - | -21.52B 4.18% | -24.60B 14.32% | -35.10B 42.68% | -42.52B 21.14% | -31.95B 24.85% | -27.21B 14.83% | -11.35B 58.29% | -5.87B 48.27% | -3.55B 39.58% | |
net debt to ebitda | 3.78 - | 3.13 17.11% | 3.52 12.16% | 3.82 8.78% | 3.81 0.51% | 3.54 6.87% | 3.30 6.93% | 1.66 49.74% | 1.50 9.48% | 1.74 15.79% | |
net income per share | 10.98 - | 11.40 3.83% | 9.42 17.35% | 11.17 18.60% | 13.17 17.84% | 4.38 66.77% | 10.22 133.50% | 10.53 3.04% | 14.32 36.04% | 11.77 17.83% | |
operating cash flow per share | 8.41 - | 10.60 26.08% | 7.01 33.88% | 14.24 103.13% | 15.37 7.95% | 13.15 14.46% | 18.09 37.59% | 14.95 17.37% | 11.86 20.65% | 12.43 4.75% | |
payables turnover | 2.29 - | 5.50 139.89% | 2.13 61.25% | 4.10 92.08% | 4.68 14.21% | 4.88 4.34% | 5.73 17.44% | 6.06 5.69% | 5.58 7.98% | 5.62 0.78% | |
receivables turnover | 1.20K - | 3.04 99.75% | 3.03 0.44% | 2.64 - | |||||||
research and ddevelopement to revenue | |||||||||||
return on tangible assets | 0.12 - | 0.12 2.58% | 0.09 27.97% | 0.10 15.78% | 0.11 8.88% | 0.04 64.60% | 0.09 118.39% | 0.10 12.44% | 0.12 28.50% | 0.08 35.23% | |
revenue per share | 64.71 - | 79.17 22.35% | 78.00 1.48% | 90.27 15.73% | 93.33 3.39% | 85.17 8.74% | 84.66 0.60% | 82.73 2.28% | 85.22 3.01% | 91.64 7.53% | |
roe | 0.17 - | 0.15 12.15% | 0.10 33.59% | 0.12 16.95% | 0.12 1.44% | 0.04 69.31% | 0.07 82.92% | 0.07 8.68% | 0.09 24.88% | 0.06 33.71% | |
roic | 0.09 - | 0.09 5.47% | 0.07 20.10% | 0.08 1.93% | 0.07 7.47% | 0.07 1.31% | 0.05 24.46% | 0.06 20.26% | 0.07 18.68% | 0.05 26.97% | |
sales general and administrative to revenue | 0.06 - | 0.08 39.30% | 0.07 6.35% | 0.03 53.47% | 0.04 22.01% | 0.04 2.44% | 0.04 2.65% | 0.05 18.02% | 0.04 21.39% | 0.04 7.38% | |
shareholders equity per share | 63.30 - | 74.82 18.18% | 93.12 24.46% | 94.43 1.41% | 109.70 16.16% | 118.78 8.28% | 151.62 27.65% | 143.76 5.18% | 156.60 8.93% | 194.13 23.96% | |
stock based compensation to revenue | 0.00 - | 0.00 99.76% | 0.00 - | 0.00 5.71% | 0.00 33.20% | 0.00 39.92% | 0.00 15.32% | 0.00 120.73% | |||
tangible asset value | -13.46B - | -11.39B 15.43% | -12.60B 10.66% | -22.80B 80.95% | -28.19B 23.66% | -16.90B 40.04% | -9.20B 45.59% | 6.12B 166.58% | 12.28B 100.59% | 17.54B 42.75% | |
tangible book value per share | -29.52 - | -24.95 15.47% | -27.61 10.63% | -49.96 80.95% | -61.77 23.66% | -37.04 40.04% | -20.15 45.60% | 13.42 166.58% | 27.12 102.14% | 39.48 45.58% | |
working capital | 15.17B - | 10.96B 27.77% | 16.10B 46.92% | 3.30B 79.50% | 12.01B 264.03% | 16.11B 34.13% | 18.66B 15.80% | -4.05B 121.68% | 11.17B 375.98% | 21.35B 91.22% |
All numbers in (except ratios and percentages)